New Key Statistics Module, Z-Score and F-Score
OTCPK:SPHRY Key Ratios
| Market Cap $ M | 37.08 |
| Enterprise Value $ M | 18.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.64 |
| Price/Sales | 5.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -0.15 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -3.30 |
| 5-y EBITDA Growth Rate % | -5.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.43 |
| EV-to-EBITDA | -2.70 |
| PEG | -- |
| Shares Outstanding M | 41.20 |
| Net Margin (%) | -92.76 |
| Operating Margin % | -123.23 |
| Pre-tax Margin (%) | -92.76 |
| Quick Ratio | 5.22 |
| Current Ratio | 5.60 |
| ROA % (ttm) | -16.39 |
| ROE % (ttm) | -22.84 |
| ROIC % (ttm) | -109.68 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.54 |
SPHRY Number of Guru Trades
SPHRY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SPHRY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SPHRY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Starpharma Holdings Ltd Insider Transactions
No Available Data
News about OTCPK:SPHRY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers